Search results
Treatment for bronchiectasis aims to reduce chest infections and symptoms, improve quality of life and lower a person’s likelihood of complications, like reduced lung function.
British Thoracic Society Guideline for bronchiectasis in adults Adam T Hill, 1 Anita L Sullivan,2 James D Chalmers,3 Anthony De Soyza,4 J Stuart Elborn,5 R Andres Floto,6,7 Lizzie Grillo,8 Kevin Gruffydd-Jones,9 Alex Harvey,10 Charles S Haworth,7 Edwin Hiscocks,11 John R Hurst,12 Christopher Johnson,7 W Peter Kelleher,13,14,15 Pallavi Bedi,16 Karen Payne,17
The ACC/AHA Joint Committee on Clinical Practice Guidelines has commissioned this guideline to focus on the evaluation of acute or stable chest pain or other anginal equivalents, in various clinical settings, with an emphasis on the diagnosis on ischemic causes.
5 maj 2017 · Guidelines generally recommend treatment in several categories: chest clearance techniques that aim to improve mucociliary clearance and therefore reduce symptoms and risk of exacerbations; mucoactive drugs, which aim to improve expectoration; anti-inflammatory therapy (of which inhaled corticosteroids [ICS] are the only widely used anti ...
Development of new treatments for bronchiectasis has focused on modulating inflammatory processes, including targeting neutrophil, macrophage, T-cell, and epithelial function to reverse underlying disease processes.
Guidelines generally recommend treatment in several categories: chest clearance techniques that aim to improve mucociliary clearance and therefore reduce symptoms and risk of exacerbations; mucoactive drugs, which aim to improve expectoration; anti-inflammatory therapy (of which inhaled corticosteroids [ICS] are the only widely used anti-inammat...
Bronchiectasis is a chronic lung disease characterised by chronic cough, sputum production and recurrent pulmonary exacerbations. It is diagnosed radiologically on high resolution computed tomography chest scan by bronchial dilatation (wider than the accompanying artery).
